This study comprises 3 stages:
1. Collection of tumor and blood samples. 2. Creation of organoid models based on tumor samples. 3. Development of functional tests to predict clinical response to treatment.
Patient aged 18 years or more
Patient with histologically confirmed, localized endometrial cancer, candidate for surgical treatment.
A high-grade endometrioid histological type and/or
P53 mutation and/or
Other active cancer less than 6 months old (with the exception of treated basal cell carcinoma of the skin).
Patient deprived of liberty, under guardianship, or subject to a legal protection measure, or unable to express consent.